•  Biosynthesis of full-sites siRNA library

Biomics is the only full-sites siRNA library biosynthesis company both at home and abroad. The company has the biosynthesis technologies on high throughput, all binding site siRNA library, capable of using full-length genes (cDNA, containing all siRNA binding sites, a best binding site and so called “RNAi drug target” also included ) as raw materials, in the same test tube in one run to biosynthesize the siRNA molecules containing all binding sites of a gene. The biosynthesis runs at low cost, with a cycle of only a week. Selection with the help of all binding sites siRNA library can ensure the selection of effective gene silencing targets and related binding sites.

•  Gene Silencing Site Screening and Identification

By virtue of its completely-biosynthesized proprietary siRNA library that contains all the binding sites, Biomics can screen and identify gene silencing targets more efficiently and accurately. At the same time, siRNA drugs which are more efficient in silencing and more selective may be developed to replace existing siRNA drugs.

•  siRNA Drug Delivery System Platform

Biomics has the unique internationally-leading technology of siRNA drug delivery system by which hydrophilic siRNA can be delivered penetrating hydrophobic cell membrane after being processed with nano technologies. We have successfully developed the drug delivery system for such tissues as skin and liver.